Tarek A. Chidiac, Site 030

Mid Ohio Oncology/Hematology, Inc,DbaColumbus, Ohio - 43219 (614-383-6000) |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS2
- SINCE2008

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
October 2008 - December 2012
Prostatic Neoplasms
Neoplasms
Placebo + Docetaxel/Prednisone
Dasatinib + Docetaxel/Prednisone



